Dr. Matthias T. Buhmann – RA, QM and Innovation Consultant

Dr. Matthias T. Buhmann has over 14 years of scientific experience, including more than 6 years in the medical device industry, with a strong focus on translating innovative technologies into highly regulated environments — particularly in the field of antimicrobial technologies.

As the owner of MDC Buhmann Consulting and Head of Biofilm Research at the Dr. Brill Institutes, he provides in-depth expertise in quality management and regulatory affairs for medical devices and antimicrobial solutions.

His specialization includes quality management systems for medical device manufacturing and the development of technical documentation, including clinical and biological evaluations, systematic literature reviews, and post-market surveillance (PMS) activities — all in alignment with the requirements of the Medical Device Regulation (MDR).

His expertise covers extensive work on antimicrobial substances, biofilms, bioadhesion, antimicrobial materials, and microbiome research. He has particular proficiency in antimicrobial technologies and the reprocessing of medical devices.

What matters to him as a speaker:
“My seminars focus on guiding participants in developing strategies tailored to their company-specific challenges within the complex regulatory landscape of medical device legislation. The most valuable learning outcomes arise from interactive problem-solving that transforms regulatory requirements into practical solutions.”